Keywords: schwarz, pharma, net, income, up, operating, loss
Schwarz Pharma net income up 65% as operating loss narrows
Article | 21 February 2001
German drugmaker Schwarz Pharma says that its full-year 2000 net incomerose 65% to 13.6 million euros ($12.5 million), while its operating loss narrowed to 3.6 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
